Redwood Investments, LLC Puma Biotechnology, Inc. Transaction History

Redwood Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$20.07 - $46.7 $6.25 Million - $14.5 Million	-311,268 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $1.57 Million - $2.27 Million	-37,992 Reduced 10.88%	311,268 $14.3 Million
Q2 2018 Aug 09, 2018	BUY	$48.3 - $68.25 $7.46 Million - $10.5 Million	154,487 Added 79.32%	349,260 $20.7 Million
Q1 2018 May 15, 2018	BUY	$59.7 - $99.25 $906,126 - $1.51 Million	15,178 Added 8.45%	194,773 $13.3 Million
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $10.6 Million - $14.9 Million	112,653 Added 168.28%	179,595 $17.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.0 - $119.75 $4.82 Million - $8.02 Million	66,942	66,942 $8.02 Million

102

29.1M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $132M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.